Evidence map›Paper›PMID 24938210›Full record

ReviewNeuropsychopharmacology : official publication of the American College of Neuropsychopharmacology2015

Developmental consequences of fetal exposure to drugs: what we know and what we still must learn.

Emily J Ross, Devon L Graham, Kelli M Money, Gregg D Stanwood

Open access · bronzeAbstract readReview
In one paragraph

Review in Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 219 papers, 9 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
219citing papers in PubMed, 9 pooled it
22.3field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

219 citing papers in PubMed, 9 syntheses or guidelines pooled it, 471 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. Pooled it
  7. Pooled it
  8. Pooled it
  9. Pooled it
  10. Trial
  11. Obstetric Pharmacoethics: An ethical framework for obstetric pharmacology.European journal of obstetrics, gynecology, and reproductive biology · 2026
    Article
  12. Article
  13. Article
  14. Observational
  15. Article
  16. Review
  17. High-resolution in utero SV2A PET imaging of the nonhuman primate brain using the NeuroEXPLORER.Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism · 2026
    Article
  18. Article
  19. Characteristics of infant deaths with positive hair toxicology.Forensic science, medicine, and pathology · 2026
    Article
  20. Article

159 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Emily J RossChemical & Physical Biology Program, Vanderbilt University, Nashville, TN, USA.
Devon L GrahamDepartment of Pharmacology, Vanderbilt University, Nashville, TN, USA.
Kelli M MoneyNeuroscience Graduate Program, Vanderbilt University, Nashville, TN, USA.
Gregg D Stanwood1] Department of Pharmacology, Vanderbilt University, Nashville, TN, USA [2] The Vanderbilt Kennedy Center for Research on Human Development, Vanderbilt University, Nashville, TN, USA.
Vanderbilt University · US

Funding

MEDICAL SCIENTIST TRAINING PROGRAMT32GM007347 · NIGMS · VANDERBILT UNIVERSITY · PI WILLIAMS, CHRISTOPHER S. · 1985 to 2023
$26.3M
Dopaminergic Modulation of Brain DevelopmentR01MH086629 · NIMH · VANDERBILT UNIVERSITY · PI STANWOOD, GREGG D · 2010 to 2014
$1.9M
GLP-1 Receptors and Psychostimulant AddictionR21DA035588 · NIDA · VANDERBILT UNIVERSITY · PI GALLI, AURELIO, STANWOOD, GREGG D · 2014 to 2015
$426k
NIDA NIH HHS R21DA035588NIGMS NIH HHS T32 GM007347NIMH NIH HHS R01 MH086629NIMH NIH HHS R01MH086629
6 · The paper itself

Abstract

Most drugs of abuse easily cross the placenta and can affect fetal brain development. In utero exposures to drugs thus can have long-lasting implications for brain structure and function. These effects on the developing nervous system, before homeostatic regulatory mechanisms are properly calibrated, often differ from their effects on mature systems. In this review, we describe current knowledge on how alcohol, nicotine, cocaine, amphetamine, Ecstasy, and opiates (among other drugs) produce alterations in neurodevelopmental trajectory. We focus both on animal models and available clinical and imaging data from cross-sectional and longitudinal human studies. Early studies of fetal exposures focused on classic teratological methods that are insufficient for revealing more subtle effects that are nevertheless very behaviorally relevant. Modern mechanistic approaches have informed us greatly as to how to potentially ameliorate the induced deficits in brain formation and function, but conclude that better delineation of sensitive periods, dose-response relationships, and long-term longitudinal studies assessing future risk of offspring to exhibit learning disabilities, mental health disorders, and limited neural adaptations are crucial to limit the societal impact of these exposures.

Indexed as

Analgesics, OpioidAnimalsBrainCentral Nervous System StimulantsFemaleFetal DevelopmentHumansNicotinePregnancyPrenatal Exposure Delayed EffectsSubstance-Related DisordersAnalgesics, OpioidCentral Nervous System StimulantsNicotine

Identifiers

PMID24938210
PMCPMC4262892
OpenAlexW2037003853

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.